Navigation Links
Oligomerix, Inc. Completes Series B Financing
Date:5/22/2013

NEW YORK, May 22, 2013 /PRNewswire/ -- Oligomerix, Inc., a privately held company pioneering the development of disease modifying therapeutics for Alzheimer's disease (AD) and related neurodegenerative disorders, announced today the completion of its Series B financing, which includes both issuance of new convertible preferred shares and warrants that would represent approximately $2.8M in new investments in the Company.  Both current investors and new investors supported the raise.

Funding from the Series B round will allow Oligomerix to rapidly advance its drug discovery programs targeting tau protein oligomers that have recently been shown to be neurotoxic, impair memory formation and cause disease progression in disease models.  The Company is developing small molecule inhibitors of tau oligomer formation and antibodies specific for tau oligomer structure that have potential biomarker, diagnostic and therapeutic applications.  Oligomerix has discovered that tau becomes a proteolytic enzyme upon forming an oligomer structure that causes it and other proteins to fragment.  Based on this unique mechanistic insight into the toxicity of tau oligomers, Oligomerix is developing small molecule inhibitors of this activity and antibodies specific for tau's self-cut ends for biomarker and therapeutic uses.

James Moe , Ph.D., MBA, president and CEO of Oligomerix, Inc., commented, "We are pleased that our investors continue to believe in the breakthrough research Oligomerix is conducting across our core programs and that we have several new investors participating in this round.  We have demonstrated ongoing key developments in both our tau aggregation inhibitor and tau protease small molecule programs as well as in developing novel antibodies for each program.  Our research has shown that extracellular tau oligomers impair me
'/>"/>

SOURCE Oligomerix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. A New Mechanism for Tau Protein Pathology in Alzheimers Disease was Presented by Oligomerix, Inc. at the Society for Neuroscience Annual Meeting
2. Leviticus Cardio Ltd. Completes a Successful Animal Trial for its Wireless Energy System for VADs
3. St. Mary Completes Phase 2 of Its Emergency Department and Trauma Center Expansion
4. Centene Corporation Completes Acquisition Of Specialty Pharmacy Leader AcariaHealth
5. bioRASI Completes Acquisition of Ukrainian CRO
6. Novira Therapeutics Completes $25 Million Series A Financing
7. BGI-Shenzhen Completes Acquisition of Complete Genomics
8. Amarantus Completes Name Change and CUSIP Change
9. Advanced Cell Diagnostics Completes $12 Million Series B Financing
10. Synthetic Biologics Completes $10.8 Million Private Placement Financing
11. Haemonetics Reports First Quarter Fiscal 2013 Results, Completes Acquisition of Palls Transfusion Medicine Business, Affirms Fiscal 2013 Earnings Guidance, Provides Preliminary Outlook for Fiscal 2014 and Announces Share Repurchase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... (PRWEB) July 10, 2014 Women ... have access to an additional family planning option. ... to contraception at all levels of the health ... formulation of a widely used contraceptive—Pfizer’s Depo-Provera® (depot ... Burkina Faso is the first of four African ...
(Date:7/10/2014)... Cleveland, Ohio (PRWEB) July 10, 2014 ... in ion channel-expressing cell lines, and the gap that ... new cells that expand its industry-leading portfolio of validated ... focuses on ion channel-expressing cell lines, as ion channels ... able to control this activity creates the potential to ...
(Date:7/10/2014)... 10, 2014 Robert Harman, DVM, Founder and ... is proud to announce the relaunch of his highly informative ... new series called “ What are Stem Cells ?” ... and straightforward foundation in the basics of stem cell therapy ... the right type of treatment when considering regenerative medicine. , ...
(Date:7/10/2014)... 2014 Senior supply chain management executives ... addressed the challenges of “Reducing Cost, Lead Time, & ... strategic sourcing. Describing the partnership of the Bio Supply ... Management Institute ( SCMI) of the University of ... at the Kroc Institute of Peace and Justice in ...
Breaking Biology Technology:Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 2Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 3Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 4Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 5Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 6Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 2Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 3Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 2Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 2Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 4
... BRIARCLIFF MANOR, N.Y. , July 23 Applications are ... Publication Professional (CMPP) examination. Qualified candidates can take the three-hour exam ... locations around the globe. , ... In order to earn the CMPP credential, candidates must ...
... NeoGenomics, Inc. (OTC Bulletin Board: NGNM) announced today that ... July 29, 2010 . , , ... has scheduled a web-cast and conference call to discuss their Q2 2010 results ... investors should dial (877) 407-9210 (domestic) and (201) 689-8049 (international) at least five ...
... specific mental ability tests are important tools for vocational guidance. ... based on differences in brain structure, and if so, can ... a first step, researchers writing in the open access journal ... tests used in vocational guidance correlate to gray matter in ...
Cached Biology Technology:Applications for the September ISMPP Certified Medical Publication Professional Exam Now Being Accepted 2Applications for the September ISMPP Certified Medical Publication Professional Exam Now Being Accepted 3NeoGenomics Schedules its Q2 2010 Earnings Release for July 29, 2010 2NeoGenomics Schedules its Q2 2010 Earnings Release for July 29, 2010 3
(Date:7/10/2014)... 2, 2014  Unisys Corporation,s (NYSE: UIS ) ... N.V., today announced that it has been selected by the ... a new Basic Provision Biometrics solution for penitentiaries across ... the contract with a solution based on its open standards-based ... of the contract is up to seven years, with the ...
(Date:7/10/2014)... July 3, 2014 According to ... Type (Swipe And Area), Material (Optical Prism, Pizeoelectric, Capacitive, ... Security and Banking & Finance), and Geography - Global ... MarketsandMarkets, the global Fingerprint Sensors Market is projected to ... CAGR of 16.8% from 2014 to 2020. ...
(Date:7/10/2014)... , July 7, 2014 According ... Research "Electronic Access Control Systems Market Global Forecast, Market ... the global Electronic Access Control systems market was valued ... to grow at a CAGR of 12.6% from 2014 ... 31,187.8 million in 2019. Browse the full ...
Breaking Biology News(10 mins):Unisys Delivers New Basic Provision Biometrics Solution to Dutch Custodial Institutions Service 2Unisys Delivers New Basic Provision Biometrics Solution to Dutch Custodial Institutions Service 3Fingerprint Sensors Market worth $14.35 Billion by 2020 2Fingerprint Sensors Market worth $14.35 Billion by 2020 3Electronic Access Control Systems Market is Expected to Reach USD 31.2 Billion Globally in 2019: Transparency Market Research 2Electronic Access Control Systems Market is Expected to Reach USD 31.2 Billion Globally in 2019: Transparency Market Research 3Electronic Access Control Systems Market is Expected to Reach USD 31.2 Billion Globally in 2019: Transparency Market Research 4Electronic Access Control Systems Market is Expected to Reach USD 31.2 Billion Globally in 2019: Transparency Market Research 5
... Stanford University and Professor Terence Tao from University of ... the George Plya Prize, which was awarded at the ... held July 12-16 in Pittsburgh, Pennsylvania. The award ... sensing and matrix completion, which enables efficient reconstruction of ...
... Scientists at Jefferson Medical College have received a four-year, ... the National Heart, Lung and Blood Institute to study ... gene expression. The study aims to find data ... develop better predictors of cardiovascular disease. ...
... LANSING, Mich. New ground broken by Michigan ... themselves from freezing temperatures and could lead to ... other extreme conditions. "This brings together two ... MSU professor of biochemistry and molecular biology. "One ...
Cached Biology News:George Pólya Prize awarded to Emmanuel Candès and Terence Tao 2Jefferson receives $3 million NIH grant to study molecular and genetic mechanisms in platelets 2Researchers discover novel mechanism protecting plants against freezing 2
RayBio Human Atherosclerosis Antibody Array 1.1 (4) with Accessory, detects 40 inflammatory factors (for lysate) Class: Antibody Array Products Product Group: Antibody Array...
Ultra Pure Grade. Used in conjunction with IPTG to identify bacterial colonies that contain recombinant plasmids by blue/white selection. X-Gal forms an intense blue precipitate in the presence of be...
Request Info...
4-Hydroxy-3-nitrophenylacetyl hapten is conjugated to SSA (Sheep serum albumin) lysine through amide bonds. This product is homologous to NP-BSA....
Biology Products: